Advanced in H1N1 Influenza

Dr. Patricia L. Winokur

Infectious Disease
200 Hawkins Dr, 
Iowa City, IA 
Accepting New Patients
Advanced in H1N1 Influenza
200 Hawkins Dr, 
Iowa City, IA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Patricia Winokur is an Infectious Disease provider in Iowa City, Iowa. Dr. Winokur is rated as an Advanced provider by MediFind in the treatment of H1N1 Influenza. Her top areas of expertise are Flu, Avian Influenza, H1N1 Influenza, and Pneumonia. Dr. Winokur is currently accepting new patients.

Her clinical research consists of co-authoring 78 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 4 articles in the study of H1N1 Influenza.

Specialties
Infectious Disease
Licenses
Internal Medicine in IA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Sanford Health
  • HMO
  • PPO
Wellmark
  • HMO
  • POS

Locations

200 Hawkins Dr, Iowa City, IA 52242

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3

78 Total Publications

AVIAN INFLUENZA VIRUS: THE NEXT PANDEMIC?
AVIAN INFLUENZA VIRUS: THE NEXT PANDEMIC?
Journal: Transactions of the American Clinical and Climatological Association
Published: August 07, 2025
Similar Doctors
Experienced in H1N1 Influenza
Dr. Michael B. Edmond
Infectious Disease
Experienced in H1N1 Influenza
Dr. Michael B. Edmond
Infectious Disease
200 Hawkins Dr, Department Of Internal Medicine, 
Iowa City, IA 
 (0.1 miles away)
319-353-8352
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Edmond is an Infectious Disease provider in Iowa City, Iowa. Dr. Edmond is rated as an Experienced provider by MediFind in the treatment of H1N1 Influenza. His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), COVID-19, Sepsis, and Severe Acute Respiratory Syndrome (SARS). Dr. Edmond is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Winokur's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile